本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ligand Pharmaceuticals Inc.

283.49
-1.2100-0.43%
盤後283.490.0025+0.00%16:29 EDT
成交量:37.28萬
成交額:1.06億
市值:56.52億
市盈率:29.20
高:285.64
開:285.63
低:280.49
收:284.70
52周最高:326.63
52周最低:163.45
股本:1,993.56萬
流通股本:1,935.39萬
量比:1.62
換手率:1.93%
股息:- -
股息率:- -
每股收益(TTM):9.71
每股收益(LYR):6.13
淨資產收益率:21.96%
總資產收益率:3.99%
市淨率:5.84
市盈率(LYR):46.25

資料載入中...

2020/06/11

重要事件披露

8-K - Current report
2020/05/08

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/07

重要事件披露

Current report, item 1.01
2020/04/06

重要事件披露

Current report, items 2.02 and 8.01
2020/04/02

重要事件披露

Current report, items 8.01 and 9.01
2020/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

重要事件披露

Current report, items 2.02 and 9.01
2020/01/10

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/10

重要事件披露

Current report, item 8.01
2019/12/23

重要事件披露

Current report, item 5.02